Posted
on December 1, 2022
The following is the latest health policy news from the federal government for the week of November 28 to December 1. Some of the language used below is taken directly from government documents.
340B
- HHS and its Health Resources and Services Administration (HRSA) have proposed revising the current 340B administrative dispute resolution process. Since the current process was introduced in 2020 HRSA has encountered policy and operational challenges with its implementation and now proposes revising it and is soliciting comment on its proposed new approach. Changes include changing the nature of the dispute resolution process, using different kinds of professionals to adjudicate disputes, moving the process closer to certain legislative requirements, and creating a process for reconsideration for those unhappy with decisions. Learn more about how the proposed rule would change the administrative dispute resolution process from this HHS notice, which also includes a link to a more detailed Federal Register notice. Comments are due by January 30.
Confidentiality of Substance Use Disorder Patient Records
- HHS and its Office for Civil Rights and the Substance Abuse and Mental Health Services Administration (SAMHSA) have proposed changes in the Confidentiality of Substance Use Disorder Patient Records under 42 CFR part 2,
…
Filed under:
340b,
Affordable Care Act,
Center for Medicare and Medicaid Innovation,
Centers for Medicare & Medicaid Services,
CMMI,
Congress,
COVID-19,
health equity,
hospitals,
MACPAC,
Medicaid,
Medicaid and CHIP Payment and Access Commission,
Medicaid and housing,
Medicaid long-term services and supports,
Medicaid regulations,
Medicare,
MedPAC,
Telehealth
Posted
on October 20, 2022
The following is the latest health policy news from the federal government for the week of October 14 to October 20. Some of the language used below is taken directly from government documents.
White House
- President Biden has signed an executive order on lowering prescription drug costs. The order directs HHS to consider additional actions to further drive down prescription drug costs, encourages it to pursue such actions through its Center for Medicare and Medicaid Innovation (CMMI), and directs HHS to submit a formal report within 90 days outlining any plans to use CMMI’s authority to lower drug costs and promote access to innovative drug therapies for Medicare beneficiaries. Find the executive order here and a fact sheet elaborating on that order here.
- The White House has released a new “National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security.” Find the plan here; learn more about its objectives and how the administration plans to go about fulfilling them from this White House news release; and about the role of the Department of Health and Human Services from this HHS news release.
Federal Emergency Management Agency (FEMA)
…
Filed under:
Centers for Medicare & Medicaid Services,
CMMI,
COVID-19,
MACPAC,
Medicaid,
Medicaid and CHIP Payment and Access Commission,
Medicaid and housing,
Medicare,
Medicare regulations,
Medicare reimbursement policy,
MedPAC
